Using pegylated interferon alfa-2b and ribavirin to treat chronic hepatitis patients infected with hepatitis c virus genotype 1: are nonresponders and relapsers different populations?

Using pegylated interferon alfa-2b and ribavirin to treat chronic hepatitis patients infected with hepatitis c virus genotype 1: are nonresponders and relapsers different populations?

The combination of pegylated interferon (PEG-INF) and ribavirin is currently the best treatment for chronic hepatitis C, providing a sustained virological response (SVR) in 54%-63% of patients. In patients infected with hepatitis C virus (HCV) genotype 1, the SVR rate is 42%-52%. To evaluate the tre...

Full description

Bibliographic Details
Main Authors: Giovanni Faria Silva, Rodrigo José Polônio, Maria Inês Moura Campos Pardini, Silvia Maria Corvino, Rita Maria Saccomano Henriques, Mari Nilce Peres, Liciana Vaz Arruda Silveira, Kunie Iabuki Rabello Coelho
Format: Article
Language:English
Published: Elsevier
Series:Brazilian Journal of Infectious Diseases
Subjects:
Hepatitis C
pegylated interferon alfa 2b
genotype 1
relapsers
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702007000600006&lng=en&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702007000600006&lng=en&tlng=en

Similar Items